Showing results (261-270 of 378) with videos related to
Sort By:
Pageof 38
Lung Cancer (Amsterdam, Netherlands)|August 19, 2007
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology GroupD Pectasides, E Samantas, G Fountzilas, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessmentI Dimopoulou, E Efstathiou, A Samakovli, et al.European Journal of Gynaecological Oncology|September 19, 2009
Clinicopathological features of primary fallopian tube carcinoma: a single institution experienceC A Papadimitriou, S Markaki, E Lianos, et al.Leukemia|September 5, 2008
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesisE Terpos, E Kastritis, M Roussou, et al.Leukemia|July 6, 2012
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myelomaM A Dimopoulos, M Roussou, M Gkotzamanidou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology GroupA Bamias, Ch Deliveliotis, G Fountzilas, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 21, 2007
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experienceD Pectasides, G Fountzilas, G Aravantinos, et al.Cancer Journal (Sudbury, Mass.)|October 9, 2007
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology GroupT Economopoulos, A Psyrri, M A Dimopoulos, et al.Cancer|June 15, 1997
A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervixC A Papadimitriou, M A Dimopoulos, N Giannakoulis, et al.Leukemia & Lymphoma|February 28, 2007
Renal failure in multiple myeloma: incidence, correlations, and prognostic significanceV Eleutherakis-Papaiakovou, A Bamias, D Gika, et al.Pageof 38